Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00012 (Tecfidera) in Relapsing-Remitting Multiple Sclerosis
NCT00168701Phase 2Completed
- Sponsor
- Biogen
- Start
- Oct 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of dimethyl fumarate in relapsing-remitting multiple sclerosis (RRMS), sponsored by Biogen. Started Oct 2004; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00168701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168701.